Der er ikke tilgængelige data om antiviral behandling af patienter, som er bærere af HBV, i forbindelse med TNF- antagonist- behandling for at undgå HBV- reaktivering.
Adequate data of treating patients who are carriers of HBV with anti-viral therapy in conjunction with TNF-antagonist therapy to prevent HBV reactivation are not available.